Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 109 (2-3), 93-99
- https://doi.org/10.1016/s0049-3848(03)00100-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in ChildrenThrombosis and Haemostasis, 2002
- The use of low molecular weight heparin in pediatric patients: A prospective cohort studyThe Journal of Pediatrics, 2000
- Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryBritish Journal of Haematology, 1999
- Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic ComplicationsThe Journal of Pediatrics, 1998
- Antithrombotic Therapy in ChildrenChest, 1998
- Benefit of Heparin in Central Venous and Pulmonary Artery CathetersChest, 1998
- Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding studyThe Journal of Pediatrics, 1996
- A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at homeThe Journal of Pediatrics, 1995
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990
- Multiple purpose central venous access in infants less than 1,000 gramsJournal of Pediatric Surgery, 1987